Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Ischemic Heart Disease

  Free Subscription


9 Am Heart J
5 Am J Cardiol
2 Am J Emerg Med
1 Am J Med
1 Angiology
1 Ann Clin Biochem
1 Arterioscler Thromb Vasc Biol
1 Atherosclerosis
1 Cardiovasc Res
3 Catheter Cardiovasc Interv
1 Circ Cardiovasc Qual Outcomes
2 Circ Genom Precis Med
2 Circ Res
4 Circulation
2 Clin Cardiol
2 Eur Heart J
1 Hypertension
3 Int J Cardiol
3 J Am Coll Cardiol
1 J Electrocardiol
5 J Thorac Cardiovasc Surg
7 N Engl J Med

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. SUZUKI T, Salzano A, Israr MZ
    Targeting the gut microbiome in coronary artery disease.
    Am Heart J. 2021 Feb 22. pii: S0002-8703(21)00056.

  2. PILGRIM T, Rothenbuhler M, Siontis GC, Kandzari DE, et al
    Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of individual patient data from five randomized trials.
    Am Heart J. 2021 Feb 17. pii: S0002-8703(21)00048.
    PubMed         Abstract available

  3. SHAHZEB KHAN M, Kristensen SL, Vaduganathan M, Kober L, et al
    Natriuretic Peptide Plasma Concentrations and Risk of Cardiovascular Versus Non-Cardiovascular Events in Heart Failure with Reduced Ejection Fraction Insights from the PARADIGM-HF and ATMOSPHERE Trials.
    Am Heart J. 2021 Feb 20. pii: S0002-8703(21)00054.
    PubMed         Abstract available

  4. GE Z, Gao XF, Kan J, Kong XQ, et al
    Comparison of 1-month Versus 12-month Dual Antiplatelet Therapy after Implantation of Drug-eluting Stents Guided by either Intravascular Ultrasound or Angiography in Patients with Acute Coronary Syndrome: Rationale and Design of Prospective, Multicent
    Am Heart J. 2021 Feb 20. pii: S0002-8703(21)00053.
    PubMed         Abstract available

  5. TANG WHW, Li XS, Wu Y, Wang Z, et al
    Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk Prospective Population Study.
    Am Heart J. 2021 Feb 21. pii: S0002-8703(21)00057.
    PubMed         Abstract available

  6. BATCHELOR WB, Damluji AA, Yong C, Fiuzat M, et al
    Am Heart J. 2021 Feb 23. pii: S0002-8703(21)00035.
    PubMed         Abstract available

  7. SNAVELY AC, Hendley N, Stopyra JP, Lenoir KM, et al
    Sex and race differences in safety and effectiveness of the HEART pathway accelerated diagnostic protocol for acute chest pain.
    Am Heart J. 2021;232:125-136.
    PubMed         Abstract available

  8. BRAIK N, Guedeney P, Behnes M, Desch S, et al
    Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trial.
    Am Heart J. 2021;232:185-193.
    PubMed         Abstract available

  9. JENTZER JC, Ahmed AM, Vallabhajosyula S, Burstein B, et al
    Shock in the cardiac intensive care unit: Changes in epidemiology and prognosis over time.
    Am Heart J. 2021;232:94-104.
    PubMed         Abstract available

    Am J Cardiol

  10. DIEZ-VILLANUEVA P, Garcia-Guimaraes MM, Macaya F, Masotti M, et al
    Spontaneous Coronary Artery Dissection and Menopause.
    Am J Cardiol. 2021 Feb 19. pii: S0002-9149(21)00147.
    PubMed         Abstract available

  11. ZAATARI G, Fintel DJ, Subacius H, Germano JJ, et al
    Comparison of Metoprolol versus Carvedilol After Acute Myocardial Infarction.
    Am J Cardiol. 2021 Feb 20. pii: S0002-9149(21)00155.
    PubMed         Abstract available

  12. ALDUJELI A, Hamadeh A, Tecson KM, Krivickas Z, et al
    Six-Month Outcomes for COVID-19 Negative Patients with Acute Myocardial Infarction Before versus During the COVID-19 Pandemic.
    Am J Cardiol. 2021 Feb 22. pii: S0002-9149(21)00161.
    PubMed         Abstract available

  13. VAHATALO J, Holmstrom L, Pakanen L, Kaikkonen K, et al
    Coronary Artery Disease as the Cause of Sudden Cardiac Death Among Victims < 50 Years of Age.
    Am J Cardiol. 2021 Feb 20. pii: S0002-9149(21)00157.
    PubMed         Abstract available

  14. MOHAMED MO, Contractor T, Abramov D, Parwani P, et al
    Sex-Based Differences in Prevalence and Outcomes of Common Acute Conditions Associated with Type 2 Myocardial Infarction.
    Am J Cardiol. 2021 Feb 20. pii: S0002-9149(21)00156.
    PubMed         Abstract available

    Am J Emerg Med

  15. CINAR T, Tanik VO, Simsek B, Gungor B, et al
    In-hospital mortality of STEMI patients: A comparison of transportation modes to PCI and non-PCI centers.
    Am J Emerg Med. 2021;40:222-224.

  16. HOANG A, Singh A, Singh A
    Comparing physicians and experienced advanced practice practitioners on the interpretation of electrocardiograms in the emergency department.
    Am J Emerg Med. 2021;40:145-147.
    PubMed         Abstract available

    Am J Med

  17. SIAK J, Flint N, Shmueli HG, Siegel RJ, et al
    The Use of Colchicine in Cardiovascular Diseases - a Systematic Review.
    Am J Med. 2021 Feb 17. pii: S0002-9343(21)00098.
    PubMed         Abstract available


  18. ZANOLI L, Gaudio A, Castellino P
    From Arterial to Cardiac Dysfunction.
    Angiology. 2021;72:301-302.

    Ann Clin Biochem

  19. FONTAINE F, Legallois D, Creveuil C, Chtourou M, et al
    EXPRESS: Is plasma level of Coenzyme Q10 a predictive marker for left ventricular remodeling after revascularization for ST-segment elevation myocardial infarction ?
    Ann Clin Biochem. 2021 Feb 23:45632211001100. doi: 10.1177/00045632211001100.
    PubMed         Abstract available

    Arterioscler Thromb Vasc Biol

  20. BYTYCI I, Shenouda R, Wester P, Henein MY, et al
    Carotid Atherosclerosis in Predicting Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Arterioscler Thromb Vasc Biol. 2021 Feb 25:ATVBAHA120315747.
    PubMed         Abstract available


  21. RAGGI P, Abele J
    Molecular imaging for risk prediction of coronary artery disease: A close or far fetched option?
    Atherosclerosis. 2021;319:118-120.

    Cardiovasc Res

  22. TRINDER M, Zekavat SM, Uddin MM, Pampana A, et al
    Apolipoprotein B is an insufficient explanation for the risk of coronary disease associated with lipoprotein(a).
    Cardiovasc Res. 2021 Feb 24. pii: 6149309. doi: 10.1093.

    Catheter Cardiovasc Interv

  23. GOLAMARI RR, Gilchrist IC
    STEMI and COVID-19: Unmasking failures and opportunities to enhance future care.
    Catheter Cardiovasc Interv. 2021;97:215-216.

    SCAI consumer survey comparing fear of COVID-19 versus heart attack or stroke (first publish date: September 4, 2020).
    Catheter Cardiovasc Interv. 2021;97:193-194.

  25. SECCO GG, Tarantini G, Mazzarotto P, Garbo R, et al
    Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience.
    Catheter Cardiovasc Interv. 2021;97:195-198.
    PubMed         Abstract available

    Circ Cardiovasc Qual Outcomes

  26. VIGANEGO F, Um EK, Ruffin J, Fradley MG, et al
    Impact of Global Budget Payments on Cardiovascular Care in Maryland: An Interrupted Time Series Analysis.
    Circ Cardiovasc Qual Outcomes. 2021 Feb 24:CIRCOUTCOMES120007110.
    PubMed         Abstract available

    Circ Genom Precis Med

  27. LIND L, Sundstrom J, Arnlov J, Ingelsson M, et al
    Life-Time Covariation of Major Cardiovascular Diseases: A 40 Year Longitudinal Study and Genetic Studies.
    Circ Genom Precis Med. 2021 Feb 26. doi: 10.1161/CIRCGEN.120.002963.
    PubMed         Abstract available

  28. BON-BARET V, Chignon A, Boulanger MC, Li Z, et al
    System Genetics Including Causal Inference Identify Immune Targets for Coronary Artery Disease and the Lifespan.
    Circ Genom Precis Med. 2021 Feb 24. doi: 10.1161/CIRCGEN.120.003196.
    PubMed         Abstract available

    Circ Res

  29. MARTINS-MARQUES T, Catarino S, Goncalves A, Miranda-Silva D, et al
    EHD1 Modulates Cx43 Gap Junction Remodeling Associated With Cardiac Diseases.
    Circ Res. 2020;126:e97-e113.
    PubMed         Abstract available

    CD31 as a Therapeutic Target in Atherosclerosis.
    Circ Res. 2020;126:1178-1189.
    PubMed         Abstract available


  31. HORIUCHI Y, Wettersten N, Maisel A
    Response by Horiuchi et al to Letter Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction".
    Circulation. 2021;143:e252-e253.

  32. Correction to: Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy.
    Circulation. 2021;143:e744.

  33. GOFF DC JR, Khan SS, Lloyd-Jones D, Arnett DK, et al
    Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond.
    Circulation. 2021;143:837-851.
    PubMed         Abstract available

  34. PUTOT A, Cottin Y, Zeller M
    Letter by Putot et al Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction".
    Circulation. 2021;143:e250-e251.

    Clin Cardiol

  35. ABULIMITI A, Nishitani-Yokoyama M, Shimada K, Kunimoto M, et al
    Prognostic impact of peak oxygen uptake and heart rate reserve in patients after off-pump coronary artery bypass grafting.
    Clin Cardiol. 2021 Feb 25. doi: 10.1002/clc.23579.
    PubMed         Abstract available

  36. CHEN Z, Wang D, Ma M, Li C, et al
    Rationale and design of the OPTIMAL-REPERFUSION trial: A prospective randomized multi-center clinical trial comparing different fibrinolysis-transfer percutaneous coronary intervention strategies in acute ST-segment elevation myocardial infarction.
    Clin Cardiol. 2021 Feb 25. doi: 10.1002/clc.23582.
    PubMed         Abstract available

    Eur Heart J

  37. REFFO E, Stritoni V, Di Salvo G
    Inflammatory syndrome in children associated with COVID-19 complicated by acute myocardial infarction.
    Eur Heart J. 2021 Feb 20. pii: 6145783. doi: 10.1093.

    Emergency Room visits in the COVID-19 pandemic.
    Eur Heart J. 2021;42:369-370.


  39. VAURA F, Kauko A, Suvila K, Havulinna AS, et al
    Polygenic Risk Scores Predict Hypertension Onset and Cardiovascular Risk.
    Hypertension. 2021 Feb 22:HYPERTENSIONAHA12016471.
    PubMed         Abstract available

    Int J Cardiol

  40. CHOUDHARY R, Gautam DK
    Optimal antiplatelet strategy in Asian patients presenting with acute coronary syndrome.
    Int J Cardiol. 2020;319:37.

  41. WANG H, Zhang Y, Shen Z, Fang L, et al
    Response to letter to the editor on "Percutaneous coronary intervention underperforms in Takayasu Arteritis".
    Int J Cardiol. 2020;319:38-39.

  42. BARBATO E, Knuuti J, Wijns W
    From fallacies to reality: Focus on fractional flow reserve.
    Int J Cardiol. 2020;319:61.

    J Am Coll Cardiol

  43. YURISTA SR, Chong CR, Badimon JJ, Kelly DP, et al
    Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC Focus Seminar.
    J Am Coll Cardiol. 2021 Feb 17. pii: S0735-1097(21)00194.
    PubMed         Abstract available

  44. WILLIAMS MC, Dweck MR, Newby DE
    Coronary Computed Tomography Angiography to Triage Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
    J Am Coll Cardiol. 2021;77:1053-1056.

  45. KOFOED KF, Engstrom T, Sigvardsen PE, Linde JJ, et al
    Prognostic Value of Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
    J Am Coll Cardiol. 2021;77:1044-1052.
    PubMed         Abstract available

    J Electrocardiol

  46. HAYIROGLU MI, Turkkan C, Tekkesin AI
    Ideal admission electrocardiographic parameters in STEMI: What else do we need to learn?
    J Electrocardiol. 2020;63:187.

    J Thorac Cardiovasc Surg

  47. LAZAR HL
    Commentary: Improving outcomes in diabetic coronary artery bypass grafting recipients: More arterial conduits, but even more medicine.
    J Thorac Cardiovasc Surg. 2021 Jan 29. pii: S0022-5223(21)00161.

    Commentary: Nothing will come of nothing: Surgical reimplantation for anomalous aortic origin of a coronary artery moves the field forward.
    J Thorac Cardiovasc Surg. 2021 Jan 19. pii: S0022-5223(21)00108.

  49. NOLY PE, Carrier M
    Commentary: Coronary artery bypass grafting surgery alone is not the only way!
    J Thorac Cardiovasc Surg. 2021 Jan 29. pii: S0022-5223(21)00166.

  50. POPE NH, Kilic A
    Commentary: Coronary artery bypass grafting in midrange ejection fraction: Charting unknown waters.
    J Thorac Cardiovasc Surg. 2021 Jan 29. pii: S0022-5223(21)00178.

  51. DEO SV, Sundaram V, Sahadevan J, Selvaganesan P, et al
    Outcomes of coronary artery bypass grafting in patients with heart failure with a midrange ejection fraction.
    J Thorac Cardiovasc Surg. 2021 Jan 23. pii: S0022-5223(21)00132.
    PubMed         Abstract available


  52. KOLTE D, Libby P, Jang IK
    New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes.
    JAMA. 2021 Feb 22. pii: 2776938. doi: 10.1001/jama.2021.0069.

    N Engl J Med

  53. JENKINS DJA, Dehghan M, Mente A, Bangdiwala SI, et al
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
    N Engl J Med. 2021 Feb 24. doi: 10.1056/NEJMoa2007123.
    PubMed         Abstract available

  54. KAISER D, Jackson CD
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:776.

  55. GEBHARD C, Regitz-Zagrosek V
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:776-777.

  56. LUCIJANIC M, Javor E, Skelin M
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:777-778.

  57. D'AMARIO D, Rodolico D, Galli M
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:778.

  58. FIOLET ATL, Cornel JH, Thompson PL
    Colchicine in Patients with Chronic Coronary Disease. Reply.
    N Engl J Med. 2021;384:778-779.

    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:777.

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.